Evidence-Based Reviews

Nontraditional therapies for treatment-resistant depression: Part 2

Author and Disclosure Information

 

References

Adverse effects of exercise are typically limited to sprains or strains; rarely, participants experience serious injuries.

Mindfulness-based interventions involve purposely paying attention in the present moment to enhance self-understanding and decrease anxiety about the future and regrets about the past, both of which complicate depression. A meta-analysis of 12 RCTs (N = 578) found this approach significantly reduced depression severity when used as an adjunctive therapy.31 There may be risks if mindfulness-based interventions are practiced incorrectly. For example, some reports have linked mindfulness-based interventions to psychotic episodes, meditation addiction, and antisocial or asocial behavior.32

Bottom Line

Nonpharmacologic options for patients with treatment-resistant depression include herbal/nutraceuticals, anti-inflammatory/immune system therapies, and devices. While research suggests some of these approaches are promising, clinicians need to carefully consider potential adverse effects, some of which may be serious.

Related Resources

Drug Brand Names

Atorvastatin • Lipitor
Brexanolone • Zulresso
Citalopram • Celexa
Fluoxetine • Prozac
Lithium • Eskalith, Lithobid
Lovastatin • Altoprev, Mevacor
Minocycline • Dynacin, Minocin
Simvastatin • Flolipid, Zocor

Pages

Recommended Reading

‘Empathy fatigue’ in clinicians rises with latest COVID-19 surge
MDedge Psychiatry
Trust is key in treating borderline personality disorder
MDedge Psychiatry
A new name for BPD?
MDedge Psychiatry
Residency programs need greater focus on BPD treatment
MDedge Psychiatry
How to engage soldiers, veterans in psychiatric treatment
MDedge Psychiatry
Gut health ‘vitally important’ for mental health
MDedge Psychiatry
New finasteride lawsuit brings renewed attention to psychiatric, ED adverse event reports
MDedge Psychiatry
Dopamine and reward: The story of social media
MDedge Psychiatry
Treating major depressive disorder after limited response to an initial agent
MDedge Psychiatry
Relapse risk increased with antidepressant discontinuation
MDedge Psychiatry